Grupo Fleury
Mr. Jeane Tsutsui is currently CEO of Grupo Fleury. She started her career at Fleury in 2001 as a cardiologist, and migrated from a medical career to an executive 14 years ago. Held the roles of Manager and Director in the areas of R&D and Knowledge Management, Executive Medical Director (2012 to 2018) and Executive Business Director (2018-2021). Graduated in Medicine at the Ribeirão Preto Medical School – USP, resided in Clinical Medicine at Hospital das Clínicas at USP and in Cardiology at Instituto do Coração (InCor) -USP. She has a doctorate in Cardiology from Faculdade de Medicina da USP, Post-doctorate from the University of Nebraska Medical Center and is a Free-Professor of Cardiology at the Faculdade de Medicina da USP. Her management background includes an MBA in Knowledge, Innovation and Technology from FIA, and executive programs at Harvard Business School, Wharton and Sloan School of Management at MIT.
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.